Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells

被引:3
|
作者
Rosado-Galindo, Heizel [1 ]
Domenech, Maribella [1 ,2 ]
机构
[1] Univ Puerto Rico Mayaguez, Bioengn Program, Mayaguez, PR 00682 USA
[2] Univ Puerto Rico Mayaguez, Dept Chem Engn, Mayaguez, PR 00682 USA
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2023年 / 11卷
基金
美国国家卫生研究院;
关键词
topography; EGFR signaling; TNBC; secretome; stemness; PHASE-II; TARGETED THERAPY; GROWTH; PROLIFERATION; RESISTANCE; PROMOTES; OVEREXPRESSION; CHALLENGES; SIGNATURE; YAP/TAZ;
D O I
10.3389/fcell.2023.1124250
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Cancer stem cells (CSC), a major culprit of drug-resistant phenotypes and tumor relapse, represent less than 2 % of the bulk of TNBC cells, making them difficult to isolate, study, and thus, limiting our understanding of the pathogenesis of the disease. Current methods for CSC enrichment, such as 3D spheroid culture, genetic modification, and stem cell conditioning, are time consuming, expensive, and unsuitable for high-throughput assays. One way to address these limitations is to use topographical stimuli to enhance CSC populations in planar culture. Physical cues in the breast tumor microenvironment can influence cell behavior through changes in the mechanical properties of the extracellular matrix (ECM). In this study, we used topographical cues on polystyrene films to investigate their effect on the proteome and stemness of standard TNBC cell lines.Methods: The topographical polystyrene-based array was generated using razor printing and polishing methods. Proteome data were analyzed and enriched bioprocesses were identified using R software. Stemness was assessed measuring CD44, CD24 and ALDH markers using flow cytometry, immunofluorescence, detection assays, and further validated with mammosphere assay. EGF/EGFR expression and activity was evaluated using enzyme-linked immunosorbent assay (ELISA), immunofluorescence and antibody membrane array. A dose-response assay was performed to further investigate the effect of surface topography on the sensitivity of cells to the EGFR inhibitor.Results: Surface roughness enriched the CSC population and modulated epidermal growth factor receptor (EGFR) signaling activity in TNBC cells. Enhanced proliferation of MDA-MB-468 cells in roughness correlated with upregulation of the epidermal growth factor (EGF) ligand, which in turn corresponded with a 3-fold increase in the expression of EGFR and a 42% increase in its phosphorylation compared to standard smooth culture surfaces. The results also demonstrated that phenotypic changes associated with topographical (roughness) stimuli significantly decreased the drug sensitivity to the EGFR inhibitor gefitinib. In addition, the proportion of CD44+/CD24-/ALDH+ was enhanced on surface roughness in both MDA-MB-231 and MDA-MB-468 cell lines. We also demonstrated that YAP/TAZ activation decreased in a roughness-dependent manner, confirming the mechanosensing effect of the topographies on the oncogenic activity of the cells.Discussion: Overall, this study demonstrates the potential of surface roughness as a culture strategy to influence oncogenic activity in TNBC cells and enrich CSC populations in planar cultures. Such a culture strategy may benefit high-throughput screening studies seeking to identify compounds with broader tumor efficacy.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
    Choi, Yu-Jeong
    Lee, Kangwook
    Yoon, Ji-Hye
    Cho, Sung-Gook
    Kim, Yun-Gyeong
    Jeong, Miso
    Hwang, Hyun-Ha
    Lee, Seo Yeon
    Jung, Se-Eun
    Ko, Seong-Gyu
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [42] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01) : 59 - 66
  • [43] Advanced Triple-Negative Breast Cancer
    Patel, Grisma
    Prince, Alison
    Harries, Mark
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [44] Immunotherapy for Triple-Negative Breast Cancer
    Cao, Yifeng
    Chen, Chuyang
    Tao, Yi
    Lin, Weifeng
    Wang, Ping
    PHARMACEUTICS, 2021, 13 (12)
  • [45] CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy
    Lemesle, Marine
    Geoffroy, Marine
    Alpy, Fabien
    Tomasetto, Catherine-Laure
    Kuntz, Sandra
    Grillier-Vuissoz, Isabelle
    CANCERS, 2022, 14 (20)
  • [46] Antitumor activity of celecoxib with docetaxel on human triple-negative breast cancer cells
    Ajikanari, Oktay
    Miaadi, Elham
    Hedayat, Mohaddeseh
    Jafari, Reza
    Asghari, Rahim
    Zolbanin, Naime Majidi
    GENE REPORTS, 2025, 38
  • [47] Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
    Rad, Sima Kianpour
    Yeo, Kenny K. L.
    Li, Runhao
    Wu, Fangmeinuo
    Liu, Saifei
    Nourmohammadi, Saeed
    Murphy, William M.
    Tomita, Yoko
    Price, Timothy J.
    Ingman, Wendy V.
    Townsend, Amanda R.
    Smith, Eric
    BIOMOLECULES, 2025, 15 (01)
  • [48] Expression of mTOR Signaling Pathway Molecules in Triple-Negative Breast Cancer
    Ito, Kei
    Ogata, Hideaki
    Honma, Naoko
    Shibuya, Kazutoshi
    Mikami, Tetuo
    PATHOBIOLOGY, 2019, 86 (5-6) : 315 - 321
  • [49] CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
    Dai, Meiou
    Zhang, Chenjing
    Ali, Ayad
    Hong, Xinyuan
    Tian, Jun
    Lo, Chieh
    Fils-Aime, Nadege
    Burgos, Sergio A.
    Ali, Suhad
    Lebrun, Jean-Jacques
    SCIENTIFIC REPORTS, 2016, 6
  • [50] The GEF-H1/PKD3 signaling pathway promotes the maintenance of triple-negative breast cancer stem cells
    Lieb, Wolfgang S.
    Lungu, Cristiana
    Tamas, Raluca
    Berreth, Hannah
    Rathert, Philipp
    Storz, Peter
    Olayioye, Monilola A.
    Hausser, Angelika
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (12) : 3423 - 3434